International Journal of Medical and Pharmaceutical Research
2024, Volume-5, Issue-6 doi: 10.5281/zenodo.12787834
Original Research Article
A Prospective Randomized Study on the Role of Topical Antibiotic Ointment in Lateral Graft Underlay Myringoplasty
Published
Dec. 19, 2024
Abstract

Background: The role of topical antibiotic ointment in post-myringoplasty care remains controversial, with limited evidence supporting its routine use. This study evaluated the efficacy of topical antibiotic ointment in lateral graft underlay myringoplasty.Methods: A prospective, randomized, double-blind controlled trial was conducted with 120 patients randomly assigned to receive either topical antibiotic ointment (n=60) or petroleum jelly (n=60) following myringoplasty. Primary outcome was graft uptake rate at 12 weeks. Secondary outcomes included infection rates, healing time, complications, and cost-effectiveness.Results: Complete graft uptake was achieved in 90.0% of the antibiotic group versus 85.0% of controls (p=0.582). Postoperative infection rates were comparable (3.3% vs 5.0%, p=0.648). Complete epithelialization at week 6 was observed in 80.0% and 75.0% of cases, respectively (p=0.509). Complication rates were similar, with granulation tissue being most common (6.7% vs 8.3%, p=0.729). The antibiotic group showed significantly higher costs per successful outcome ($272.8 ± 42.6 vs $256.9 ± 38.4, p=0.038).Conclusion: Routine use of topical antibiotic ointment following lateral graft underlay myringoplasty does not significantly improve surgical outcomes and increases treatment costs. These findings support more judicious use of topical antibiotics in uncomplicated myringoplasty cases.

Recommended Articles
Loading Image...
Volume-5, Issue-6
Citations
225 Views
313 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved